Sevion Therapeutics

Sevion Therapeutics

Biopharmaceutical innovations targeting cancer and immunological diseases with unique antibody technology platforms. Learn more

Employees
Market cap
-
Enterprise valuation
€11—16m (Dealroom.co estimates May 2015.)
San Diego California (HQ)
Authorizing premium user...